Edg5 antagonists (Merck)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameEdg5 antagonists (Merck)
Drug Alias Namesphingosine 1-phosphate 2 antagonist (Merck)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor 2 antagonists
TargetsSphingosine 1-phosphate receptor 2
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A